| For: | Ni CX, Xu JJ, Pang Y, Xu JJ. Treatment strategies targeting the phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin pathway against triple-negative breast cancer. World J Clin Oncol 2025; 16(5): 104623 [PMID: 40503407 DOI: 10.5306/wjco.v16.i5.104623] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v16/i5/104623.htm |
| Number | Citing Articles |
| 1 |
Ting Yang, Yiming Lu, Pengfei Yu, Jiahui Chen, Xiangdong Cheng. Remodeling the Immune Microenvironment: Engineering IL-2 Variants to Overcome Clinical Bottlenecks in PD-1 Inhibitor plus Chemotherapy. Critical Reviews in Oncology/Hematology 2026; doi: 10.1016/j.critrevonc.2026.105469
|
| 2 |
Azza Suliman, Arij Fouzat Hassan, Sumayyah Saeed, Ala-Eddin Al Moustafa, Ashraf Khalil, Abdelbary Elhissi. Liposomal delivery of DK14 chalcone analogue: A promising therapeutic strategy against triple-negative breast cancer. Journal of Drug Delivery Science and Technology 2026; 115 doi: 10.1016/j.jddst.2025.107601
|